224 related articles for article (PubMed ID: 12489489)
1. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
[TBL] [Abstract][Full Text] [Related]
2. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
3. The role of heparanase in diseases of the glomeruli.
Szymczak M; Kuźniar J; Klinger M
Arch Immunol Ther Exp (Warsz); 2010 Feb; 58(1):45-56. PubMed ID: 20049646
[TBL] [Abstract][Full Text] [Related]
4. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix in human diabetic nephropathy: reduced expression of heparan sulphate in skin basement membrane.
van der Pijl JW; Daha MR; van den Born J; Verhagen NA; Lemkes HH; Bucala R; Berden JH; Zwinderman AH; Bruijn JA; van Es LA; van der Woude FJ
Diabetologia; 1998 Jul; 41(7):791-8. PubMed ID: 9686920
[TBL] [Abstract][Full Text] [Related]
6. Degradation of basement membrane by prostate tumor heparanase.
Kosir MA; Wang W; Zukowski KL; Tromp G; Barber J
J Surg Res; 1999 Jan; 81(1):42-7. PubMed ID: 9889056
[TBL] [Abstract][Full Text] [Related]
7. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.
Toyoda M; Najafian B; Kim Y; Caramori ML; Mauer M
Diabetes; 2007 Aug; 56(8):2155-60. PubMed ID: 17536064
[TBL] [Abstract][Full Text] [Related]
8. [Morphology of basement membrane and associated matrix proteins in normal and pathological tissues].
Nerlich A
Veroff Pathol; 1995; 145():1-139. PubMed ID: 8638427
[TBL] [Abstract][Full Text] [Related]
9. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
De Muro P; Fresu P; Formato M; Tonolo G; Mameli M; Maioli M; Sanna GM; Cherchi GM
J Nephrol; 2002; 15(3):290-6. PubMed ID: 12113601
[TBL] [Abstract][Full Text] [Related]
10. A synthetic heparanase inhibitor reduces proteinuria in passive Heymann nephritis.
Levidiotis V; Freeman C; Punler M; Martinello P; Creese B; Ferro V; van der Vlag J; Berden JH; Parish CR; Power DA
J Am Soc Nephrol; 2004 Nov; 15(11):2882-92. PubMed ID: 15504941
[TBL] [Abstract][Full Text] [Related]
11. Human prostate carcinoma cells produce extracellular heparanase.
Kosir MA; Quinn CC; Zukowski KL; Grignon DJ; Ledbetter S
J Surg Res; 1997 Jan; 67(1):98-105. PubMed ID: 9070190
[TBL] [Abstract][Full Text] [Related]
12. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
13. Diabetic glomerulosclerosis--immunogold ultrastructural studies on the glomerular distribution of type IV collagen and heparan sulphate proteoglycan.
Woodrow D; Moss J; Shore I; Spiro RG
J Pathol; 1992 May; 167(1):49-58. PubMed ID: 1625058
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of heparanase in human abdominal aortic aneurysm].
Wu J; Jing Z
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1378-80. PubMed ID: 12509917
[TBL] [Abstract][Full Text] [Related]
15. A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer.
Joyce JA; Freeman C; Meyer-Morse N; Parish CR; Hanahan D
Oncogene; 2005 Jun; 24(25):4037-51. PubMed ID: 15806157
[TBL] [Abstract][Full Text] [Related]
16. Heparanase induces a differential loss of heparan sulphate domains in overt diabetic nephropathy.
Wijnhoven TJ; van den Hoven MJ; Ding H; van Kuppevelt TH; van der Vlag J; Berden JH; Prinz RA; Lewis EJ; Schwartz M; Xu X
Diabetologia; 2008 Feb; 51(2):372-82. PubMed ID: 18058084
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy.
Makino H; Yamasaki Y; Haramoto T; Shikata K; Hironaka K; Ota Z; Kanwar YS
Lab Invest; 1993 Jan; 68(1):45-55. PubMed ID: 8423676
[TBL] [Abstract][Full Text] [Related]
18. Regulation of basement membrane heparan sulfate proteoglycan, perlecan, gene expression in glomerular epithelial cells by high glucose medium.
Kasinath BS; Grellier P; Choudhury GG; Abboud SL
J Cell Physiol; 1996 Apr; 167(1):131-6. PubMed ID: 8698830
[TBL] [Abstract][Full Text] [Related]
19. High heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly T; Miao HQ; Yang Y; Navarro E; Kussie P; Huang Y; MacLeod V; Casciano J; Joseph L; Zhan F; Zangari M; Barlogie B; Shaughnessy J; Sanderson RD
Cancer Res; 2003 Dec; 63(24):8749-56. PubMed ID: 14695190
[TBL] [Abstract][Full Text] [Related]
20. Hyperpigmentation in human solar lentigo is promoted by heparanase-induced loss of heparan sulfate chains at the dermal-epidermal junction.
Iriyama S; Ono T; Aoki H; Amano S
J Dermatol Sci; 2011 Dec; 64(3):223-8. PubMed ID: 22005029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
